Search This Blog

Monday, September 24, 2018

Loxo Oncology granted orphan status for solid tumors treatment


The FDA granted Loxo Oncology orphan status for its treatment of solid tumors with neurotrophic tyrosine receptor kinase-fusion proteins.
https://thefly.com/landingPageNews.php?id=2794783
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)